Overview and Scope
Immunosuppressant refers to a medication that prevents the immune system from attacking healthy cells and tissues. These medications are used to stop transplant rejection in recipients of stem cell and organ transplants. The medications also address the symptoms of autoimmune diseases. Immunosuppressants market are potent medications that need to be carefully monitored to prevent side effects.
Sizing and Forecast
The immunosuppressants market size has grown rapidly in recent years. It will grow from $25.94 billion in 2023 to $29.72 billion in 2024 at a compound annual growth rate (CAGR) of 14.6%. The growth in the historic period can be attributed to transplant medicine advancements, drug development and innovation, regulatory approvals, rise in transplant surgeries, clinical efficacy and safety.
The immunosuppressants market size is expected to see rapid growth in the next few years. It will grow to $48.88 billion in 2028 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to targeted therapies and precision medicine, advancements in biologics and biosimilars, immunotherapy combinations, gene therapy and immunomodulation, drug delivery innovations. Major trends in the forecast period include expanded indications, regulatory and safety considerations, precision medicine approaches, telehealth and remote monitoring, biosimilars and generics.
Order your report now for swift delivery, visit the link:
https://thebusinessresearchcompany.com/report/immunosuppressant-global-market-report
Segmentation & Regional Insights
The immunosuppressants market covered in this report is segmented –
1) By Drug Class: Corticosteroids, Monoclonal Antibodies (mAbs), Calcineurin Inhibitors, mTOR Inhibitors, Anti-Proliferative Agents, Other Drug Classes
2) By Indication: Organ Transplantation, Autoimmune Disorders, Non-Autoimmune Inflammatory Diseases
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
North America was the largest region in the immunosuppressants market in 2023. The regions covered in the immunosuppressants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=3467&type=smp
Major Driver Impacting Market Growth
The surge in organ transplant procedures such as kidney and liver transplants due to the rise in incidences of organ failure is the major factor driving the immunosuppressant market’s growth. For instance, according to the American Kidney Fund, a US-based health organization, on the national transplant waiting list in June 2022, there will be more than 106,000 people, of whom 92,000 (or 87%) are waiting for a kidney transplant in the US. The increasing number of cases of organ transplants and incidences of organ failure in patients is therefore expected to drive immunosuppressants market growth.
Key Industry Players
Major companies operating in the immunosuppressants market report are Pfizer Inc., Johnson & Johnson Services Inc., BASF SE, F Hoffmann La Roche Ltd., AbbVie Inc., Allergan plc, Novartis AG, Sanofi SA, Bristol-Myers Squibb Co., GlaxoSmithKline plc, Covestro AG, Mylan Laboratories Inc., Teva Pharmaceuticals USA Inc., Astellas Pharma Inc., Sandoz Inc., Aurobindo Pharma Limited, Hikma Pharmaceuticals plc, Intas Pharmaceuticals Ltd., Zydus Lifesciences Limited, Glenmark Pharmaceuticals Ltd., Fresenius Kabi USA, Lupin Pharmaceuticals Inc., Strides Pharma Inc., Accord Healthcare Ltd., RPG Life Sciences Limited, Genzyme Transgenics Corp., Akriti Pharmaceuticals Pvt. Ltd., SEBELA PHARMACEUTICALS Inc., Healthy Life Pharma Private Limited, Apotex Inc
The immunosuppressants market report table of contents includes:
1. Executive Summary
2. Immunosuppressants Market Characteristics
3. Immunosuppressants Market Trends And Strategies
4. Immunosuppressants Market – Macro Economic Scenario
5. Global Immunosuppressants Market Size and Growth
.
.
.
31. Immunosuppressants Market Other Major And Innovative Companies
32. Global Immunosuppressants Market Competitive Benchmarking
33. Global Immunosuppressants Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Immunosuppressants Market
35. Immunosuppressants Market Future Outlook and Potential Analysis
36.Appendix
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
